Providing sustained transgene induction through affinity-based drug delivery.

Area of Science:

• Biomaterials Science
• Gene Therapy
• Drug Delivery Systems

Background:

• Small molecule gene expression activators are crucial for gene therapy, tissue engineering, and regenerative medicine.
• Achieving sustained gene expression requires long-term, controlled drug delivery systems.
• Conventional diffusion-based polymer delivery systems have limitations in prolonging drug release.

Purpose of the Study:

• To evaluate the capacity of insoluble polymers with high cyclodextrin (CD) affinity groups for controlled doxycycline delivery.
• To assess the duration and efficacy of transgene expression induced by doxycycline released from these affinity-based polymers.
• To demonstrate the broad applicability of this drug delivery platform for various transgene inducers.

Main Methods:

• Synthesized insoluble polymers with varying proportions of cyclodextrin (CD) affinity groups (gamma-CD, beta-CD) and a non-affinity control (linear dextran).
• Determined initial drug loading capacity of doxycycline in different polymer formulations.
• Assessed doxycycline release kinetics and transgene expression activation in genetically modified cells.
• Evaluated drug stability using a bacterial zone of inhibition assay.

Main Results:

• Initial doxycycline loading was proportional to CD affinity: ~8% in gamma-CD polymers, ~7% in beta-CD polymers, and ~4.5% in control polymers.
• Affinity-based polymers sustained transgene expression activation for up to three weeks.
• Bacterial zone of inhibition assays confirmed drug stability and sustained availability for weeks longer in affinity-based polymers compared to controls.
• Theoretical calculations indicated broad utility of CD polymers for binding various transgene inducers.

Conclusions:

• Insoluble polymers functionalized with cyclodextrin affinity groups provide a robust platform for sustained delivery of gene expression activators.
• This controlled release system significantly prolongs the duration of transgene expression compared to non-affinity systems.
• The demonstrated broad utility suggests potential applications in advanced therapeutic strategies requiring long-term gene modulation.